Moreover, Kunz et al evaluated 98 patients with nonenhancing glioma, classified according to 2016 WHO classification, and showed that dynamic FET PET can provide prognostic information independent of WHO grade and IDH mutational status.73 Here, IDH1 is linked to central nervous system cancer.